eNeura SpringTMS Post-Market Observational U.S. Study of Migraine

Status: Completed
Location: See all (7) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY

A multi-center, prospective, non-randomized, single arm, open label, post-market, observational study to evaluate the use of the eneura, springtms system in reduction of migraine headache symptoms.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: No
View:

• Patients 18 to 65 years of age;

• Patients able to understand and communicate in English;

• Migraine with or without aura;

• 4-25 headache days per month (confirmed by 1-month baseline diary, minimum of 5 complete headache-free days/month);

• Understand and willing to provide diary and survey data.

Locations
United States
Arizona
Mayo Clinic
Phoenix
California
UCLA Headache Research and Treatment Program
Los Angeles
Stanford Headache Program
Stanford
Maryland
Mid Atlantic Permanente Medical Group-Kaiser
Rockville
New York
Albert Einstein College of Medicine
Bronx
Ohio
The Cleveland Clinic Center for Headache and Pain
Cleveland
Pennsylvania
Jefferson Headache Center
Philadelphia
Time Frame
Start Date: December 1, 2014
Completion Date: July 1, 2016
Participants
Target number of participants: 263
Treatments
TMS Treatment
TMS( transcranial magnetic stimulation) -treatment for headache
Related Therapeutic Areas
Sponsors
Leads: eNeura, Inc.

This content was sourced from clinicaltrials.gov

Similar Clinical Trials